Common variable immunodeficiency with infective bronchiectasis exacerbation — SCE Acute Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Treat infection promptly and liaise with immunology about replacement therapy and prevention strategy
Patients with antibody deficiency and bronchiectasis are at high risk of bacterial respiratory infection and need prompt antimicrobial treatment, sputum microbiology and immunology review of replacement therapy. Infection despite treatment does not mean immunoglobulin should be stopped; dosing, adherence and bronchiectasis care need review. Preventing recurrent infection is part of acute and longitudinal management.
Reference: British Society for Immunology guidance; BTS bronchiectasis guideline